Literature DB >> 28215840

Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.

Pavla Brachova1, Nehemiah S Alvarez2, Bradley J Van Voorhis3, Lane K Christenson4.   

Abstract

OBJECTIVE: Ovarian carcinomas that originate from fallopian epithelial cells are suggested to arise due to repeated exposure to ovulatory follicular fluid (FF). Mechanistic explanation(s) for how this occurs are unknown. Here, we sought to understand if FF exposure to fallopian epithelial cells could induce DNA damage and expression of a known family of DNA mutators, apolipoprotein B mRNA editing enzyme, catalytic polypeptide (APOBEC) cytidine deaminases.
METHODS: Follicular fluid and matched patient plasma samples were obtained from donors. Fallopian epithelial cells (FT33-TAg, FT189, FT190, and FT194) were cultured with FF or plasma for 24h, and cell proliferation and DNA damage were assessed. Effects of FF on Apobec gene expression were determined by qRT-PCR and western blot analyses. Fallopian epithelial cells were transfected with an APOBEC3A expression vector and DNA damage was assessed.
RESULTS: Follicular fluid exposure increased epithelial cell proliferation as measured by three independent methods, and DNA damage accumulation as assessed using three independent measures. This effect was specific to FF, as matched patient plasma did not have the same effects. Increased expression of Apobec3a was observed in fallopian epithelial cells following exposure to 5 of 8 patient FF samples, and transient overexpression of APOBEC3A was sufficient to induce double strand DNA breaks.
CONCLUSIONS: Follicular fluid can induce cell proliferation and DNA damage accumulation in cultured fallopian epithelial cells. Increased expression of APOBEC3A, a known DNA mutator, may explain the high incidence of DNA damage after FF exposure. The role of Apobec3a in ovulation-induced inflammation warrants further investigation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apobec; DNA damage; Fallopian tube; Follicular fluid; Ovarian cancer; Ovulation

Mesh:

Substances:

Year:  2017        PMID: 28215840      PMCID: PMC5447478          DOI: 10.1016/j.ygyno.2017.02.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  39 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.

Authors:  Shelby M King; Tyvette S Hilliard; Lucia Y Wu; Randal C Jaffe; Asgerally T Fazleabas; Joanna E Burdette
Journal:  Endocr Relat Cancer       Date:  2011-09-20       Impact factor: 5.678

Review 4.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

5.  Do alterations in follicular fluid proteases contribute to human infertility?

Authors:  Lisa Marii Cookingham; Bradley J Van Voorhis; Mario Ascoli
Journal:  J Assist Reprod Genet       Date:  2015-02-15       Impact factor: 3.412

6.  Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction?

Authors:  U Büscher; F C Chen; H Kentenich; H Schmiady
Journal:  Hum Reprod       Date:  1999-01       Impact factor: 6.918

7.  p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.

Authors:  Irene M Ward; Kay Minn; Jan van Deursen; Junjie Chen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis.

Authors:  Angela Lau; Alexandra Kollara; Elizabeth St John; Alicia A Tone; Carl Virtanen; Ellen M Greenblatt; W Allan King; Theodore J Brown
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-01

Review 9.  AID/APOBEC deaminases and cancer.

Authors:  Stefan Rebhandl; Michael Huemer; Richard Greil; Roland Geisberger
Journal:  Oncoscience       Date:  2015-04-28

10.  Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.

Authors:  Stav Sapoznik; Keren Bahar-Shany; Hadar Brand; Yishay Pinto; Orshay Gabay; Efrat Glick-Saar; Chen Dor; Oranit Zadok; Iris Barshack; Adi Zundelevich; Einav Nili Gal-Yam; Yuval Yung; Ariel Hourvitz; Jacob Korach; Mario Beiner; Jasmine Jacob; Erez Y Levanon; Michal Barak; Sarit Aviel-Ronen; Keren Levanon
Journal:  Neoplasia       Date:  2016-02       Impact factor: 5.715

View more
  3 in total

Review 1.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

Review 2.  Precision gene editing technology and applications in nephrology.

Authors:  Zachary WareJoncas; Jarryd M Campbell; Gabriel Martínez-Gálvez; William A C Gendron; Michael A Barry; Peter C Harris; Caroline R Sussman; Stephen C Ekker
Journal:  Nat Rev Nephrol       Date:  2018-11       Impact factor: 28.314

3.  WNT and inflammatory signaling distinguish human Fallopian tube epithelial cell populations.

Authors:  Ian M Rose; Mallikarjun Bidarimath; Alex Webster; Andrew K Godwin; Andrea Flesken-Nikitin; Alexander Yu Nikitin
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.